Shria Parambi’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)


Figure. 1a-d: A solitary lesion covered with brownish crusts in the left temporal region (a), removed with elliptical excision (b,c). The remaining defect was closed by single interrupted sutures (d).
Figure. 2a-d: An atrophic lesion, measuring 1 cm in diameter, characterized by superficial telangiectasias and a pearly edge, was observed in the area of the nasal apex (a). The lesion was removed through elliptical/ oval excision (b), and the remaining defect was addressed with an island flap (c) and closed with single interrupted sutures (d). (e) Postoperative image after 4 weeks.
Figure. 3a-c: A single lesion, measured 1 cm in diameter, located in the sacral area, with an irregular shape and an uneven hyperpigmented border, aligning with the surrounding skin (a). The lesion was removed with an elliptical excision (b) and the remaining defect was closed by single interrupted sutures (c).
BCCs after Lisinopril Intake -Significant Connections to The Drug Related Photo- (Nitroso)-Carcinogenesis in The Context of Oncopharmacogenesis
  • Article
  • Full-text available

March 2024

·

43 Reads

Journal of Clinical Research in Dermatology

·

Shria Parambi

·

Shafali Khanom

·

An 80-year-old female presented to the dermatology department due to an atrophic lesion in the area of the nasal apex, dating for the past 5-6 years. Moreover, there was a slowly developing tumor-like growth in her left temporal region, initially noticed 1-2 years ago. Over the last month, the formation began to bleed upon light touch. Furthermore, there was another lesion in the sacral area with an irregular hyperpigmented edge, also dating back 1-2 years. The patient denied having any allergies or family history of skin malignancies. Regarding comorbidities, she underwent cholecystectomy in 2016. She has been managing arterial hypertension with lisinopril dehydrate 10 mg once daily for the past 10 years. Additionally, she has been treating vertigo with a daily intake of betahistine dihydrochloride 16 mg for the same duration. She is also taking spironolactone 25 mg once daily at noon and diosmin 600 mg once daily at noon both for the past two months (prior to the consultation). The patient presented with a request for physical evaluation of the lesions and further therapeutic approach to be established.

Download